TrialBreast cancer research : BCR2019

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.

Barbara Adamo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.